141 related articles for article (PubMed ID: 11566494)
1. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer.
Rajnakova A; Moochhala S; Goh PM; Ngoi S
Cancer Lett; 2001 Oct; 172(2):177-85. PubMed ID: 11566494
[TBL] [Abstract][Full Text] [Related]
2. Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.
Li HL; Sun BZ; Ma FC
World J Gastroenterol; 2004 Jul; 10(13):1862-6. PubMed ID: 15222024
[TBL] [Abstract][Full Text] [Related]
3. Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.
Wang YZ; Cao YQ; Wu JN; Chen M; Cha XY
World J Gastroenterol; 2005 Jan; 11(1):46-50. PubMed ID: 15609395
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features.
Feng CW; Wang LD; Jiao LH; Liu B; Zheng S; Xie XJ
BMC Cancer; 2002 Apr; 2():8. PubMed ID: 11978184
[TBL] [Abstract][Full Text] [Related]
5. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.
Kasper HU; Wolf H; Drebber U; Wolf HK; Kern MA
World J Gastroenterol; 2004 Jul; 10(13):1918-22. PubMed ID: 15222037
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression correlates with nuclear p53 accumulation in gastric carcinoma.
Shun CT; Wu MS; Huang SP; Wang HP; Chuang SM; Lin JT
Hepatogastroenterology; 2003; 50(52):988-92. PubMed ID: 12845964
[TBL] [Abstract][Full Text] [Related]
7. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
8. Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma.
Yamaguchi K; Saito H; Oro S; Tatebe S; Ikeguchi M; Tsujitani S
Oncology; 2005; 68(4-6):471-8. PubMed ID: 16020977
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.
Gallo O; Schiavone N; Papucci L; Sardi I; Magnelli L; Franchi A; Masini E; Capaccioli S
Am J Pathol; 2003 Aug; 163(2):723-32. PubMed ID: 12875991
[TBL] [Abstract][Full Text] [Related]
10. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer.
Kong G; Kim EK; Kim WS; Lee KT; Lee YW; Lee JK; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2002 Aug; 17(8):914-21. PubMed ID: 12164968
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer.
Song ZJ; Gong P; Wu YE
World J Gastroenterol; 2002 Aug; 8(4):591-5. PubMed ID: 12174362
[TBL] [Abstract][Full Text] [Related]
14. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis.
Fu S; Ramanujam KS; Wong A; Fantry GT; Drachenberg CB; James SP; Meltzer SJ; Wilson KT
Gastroenterology; 1999 Jun; 116(6):1319-29. PubMed ID: 10348815
[TBL] [Abstract][Full Text] [Related]
15. Expression and activities of three inducible enzymes in the healing of gastric ulcers in rats.
Guo JS; Cho CH; Wang WP; Shen XZ; Cheng CL; Koo MW
World J Gastroenterol; 2003 Aug; 9(8):1767-71. PubMed ID: 12918117
[TBL] [Abstract][Full Text] [Related]
16. Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer.
Song ZY; Wen SQ; Peng JP; Huang X; Qian KD
World J Gastroenterol; 2004 May; 10(9):1250-5. PubMed ID: 15112337
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival.
Li LG; Xu HM
World J Gastroenterol; 2005 May; 11(17):2539-44. PubMed ID: 15849807
[TBL] [Abstract][Full Text] [Related]
18. In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: effect of cyclooxygenase activity on nitric oxide production.
Uno K; Iuchi Y; Fujii J; Sugata H; Iijima K; Kato K; Shimosegawa T; Yoshimura T
J Pharmacol Exp Ther; 2004 Jun; 309(3):995-1002. PubMed ID: 14988416
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma.
Li W; Xu RJ; Jiang LH; Shi J; Long X; Fan B
Med Oncol; 2005; 22(1):63-70. PubMed ID: 15750198
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
Wilson KT; Fu S; Ramanujam KS; Meltzer SJ
Cancer Res; 1998 Jul; 58(14):2929-34. PubMed ID: 9679948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
